Experimental and Clinical Psychopharmacology

1.6(top 50%)

impact factor

2.4K(top 10%)

papers

63.9K(top 5%)

citations

111(top 5%)

h-index

1.6(top 50%)

impact factor

2.5K

all documents

66.9K

doc citations

169(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey.	Experimental and Clinical Psychopharmacology	1994	1,126
2	Impulsive and self-control choices in opioid-dependent patients and non-drug-using control patients: Drug and monetary rewards.	Experimental and Clinical Psychopharmacology	1997	732
3	Hyperbolic temporal discounting in social drinkers and problem drinkers.	Experimental and Clinical Psychopharmacology	1998	539
4	Impulsive and self-control choices in opioid-dependent patients and non-drug-using control patients: Drug and monetary rewards.	Experimental and Clinical Psychopharmacology	1997	532
5	Opioids and the treatment of chronic pain: Controversies, current status, and future directions.	Experimental and Clinical Psychopharmacology	2008	528
6	Delay discounting of real and hypothetical rewards.	Experimental and Clinical Psychopharmacology	2003	527
7	Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.	Experimental and Clinical Psychopharmacology	2003	459
8	An algorithm for identifying nonsystematic delay-discounting data.	Experimental and Clinical Psychopharmacology	2008	423
9	The balloon analogue risk task (BART) differentiates smokers and nonsmokers.	Experimental and Clinical Psychopharmacology	2003	416
10	Understanding the role of impulsivity and externalizing psychopathology in alcohol abuse: Application of the UPPS Impulsive Behavior Scale.	Experimental and Clinical Psychopharmacology	2003	371
11	Relative reinforcing efficacy of alcohol among college student drinkers.	Experimental and Clinical Psychopharmacology	2006	344
12	A brief history of the development of antidepressant drugs: From monoamines to glutamate.	Experimental and Clinical Psychopharmacology	2015	344
13	Craving is associated with smoking relapse: Findings from three prospective studies.	Experimental and Clinical Psychopharmacology	1997	324
14	Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.	Experimental and Clinical Psychopharmacology	2003	309
15	Modeling drug consumption in the clinic using simulation procedures: Demand for heroin and cigarettes in opioid-dependent outpatients.	Experimental and Clinical Psychopharmacology	1999	288
16	Neurocognitive impairment associated with alcohol use disorders: Implications for treatment.	Experimental and Clinical Psychopharmacology	2002	286
17	Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women.	Experimental and Clinical Psychopharmacology	2007	280
18	Nicotine and smoking: A review of effects on human performance.	Experimental and Clinical Psychopharmacology	1994	279
19	Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers.	Experimental and Clinical Psychopharmacology	2008	278
20	A 5-trial adjusting delay discounting task: Accurate discount rates in less than one minute.	Experimental and Clinical Psychopharmacology	2014	274
21	Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression.	Experimental and Clinical Psychopharmacology	1997	266
22	Bupropion sustained release treatment decreases craving for video games and cue-induced brain activity in patients with Internet video game addiction.	Experimental and Clinical Psychopharmacology	2010	260
23	Delay Discounting of Potentially Real and Hypothetical Rewards: II. Between- and Within-Subject Comparisons.	Experimental and Clinical Psychopharmacology	2004	258
24	A modified exponential behavioral economic demand model to better describe consumption data.	Experimental and Clinical Psychopharmacology	2015	256
25	Discounting of delayed rewards in opioid-dependent outpatients: Exponential or hyperbolic discounting functions?	Experimental and Clinical Psychopharmacology	1999	255
26	Executive functioning: A conceptual framework for alcohol-related aggression.	Experimental and Clinical Psychopharmacology	2000	247
27	"Loss of control" in alcoholism and drug addiction: A neuroscientific interpretation.	Experimental and Clinical Psychopharmacology	2000	246
28	Relapse prevention as a psychosocial treatment: A review of controlled clinical trials.	Experimental and Clinical Psychopharmacology	1996	238
29	Priming effects with drugs and other reinforcers.	Experimental and Clinical Psychopharmacology	1996	237
30	Development and validation of the Wisconsin Smoking Withdrawal Scale.	Experimental and Clinical Psychopharmacology	1999	237
31	Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans.	Experimental and Clinical Psychopharmacology	1999	234
32	Reliability and validity of a demand curve measure of alcohol reinforcement.	Experimental and Clinical Psychopharmacology	2009	233
33	Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis.	Experimental and Clinical Psychopharmacology	2012	227
34	Three-month stability of delay and probability discounting measures.	Experimental and Clinical Psychopharmacology	2006	224
35	Craving is associated with smoking relapse: Findings from three prospective studies.	Experimental and Clinical Psychopharmacology	1997	224
36	Hyperbolic temporal discounting in social drinkers and problem drinkers.	Experimental and Clinical Psychopharmacology	1998	217
37	Expectancy challenge and drinking reduction: Process and structure in the alcohol expectancy network.	Experimental and Clinical Psychopharmacology	1998	205
38	Development and validation of the Wisconsin Smoking Withdrawal Scale.	Experimental and Clinical Psychopharmacology	1999	203
39	The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers.	Experimental and Clinical Psychopharmacology	2001	201
40	Moderate drug use and delay discounting: A comparison of heavy, light, and never smokers.	Experimental and Clinical Psychopharmacology	2007	201
41	Pathological gamblers discount probabilistic rewards less steeply than matched controls.	Experimental and Clinical Psychopharmacology	2009	197
42	Identification and management of nonsystematic purchase task data: Toward best practice.	Experimental and Clinical Psychopharmacology	2015	195
43	The use of crowdsourcing in addiction science research: Amazon Mechanical Turk.	Experimental and Clinical Psychopharmacology	2019	193
44	Computerized behavior therapy for opioid-dependent outpatients: A randomized controlled trial.	Experimental and Clinical Psychopharmacology	2008	188
45	Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence.	Experimental and Clinical Psychopharmacology	2002	184
46	Delay discounting in current and former marijuana-dependent individuals.	Experimental and Clinical Psychopharmacology	2010	184
47	A review of the effects of perceived drug use opportunity on self-reported urge.	Experimental and Clinical Psychopharmacology	2001	179
48	Delay discounting is associated with treatment response among cocaine-dependent outpatients.	Experimental and Clinical Psychopharmacology	2011	176
49	The balloon analogue risk task (BART) differentiates smokers and nonsmokers.	Experimental and Clinical Psychopharmacology	2003	175
50	Disinhibitory psychopathology and delay discounting in alcohol dependence: Personality and cognitive correlates.	Experimental and Clinical Psychopharmacology	2009	173

Scientometrics

Overviews

Citing Bodies

Experimental and Clinical Psychopharmacology

Top Articles